Dr Andy Vinter

Founder and Chairman

Andy is the Founder of Cresset. His ground breaking research on new virtual screening technology formed the scientific foundation of the company and has underpinned our technical development ever since. He is dedicated to investigating realistic explanations for drug and hormone interactions on biological targets at the molecular level by computational means.

Andy has over forty years’ experience in the pharmaceutical industry with Beechams, Ciba, Maybridge, The Wellcome Foundation and SmithKline & French. Since 1990 he has been a Scientific Consultant and Honorary Research Fellow at the University of Cambridge and has held five Visiting Professorships including UCL, KCL and Utrecht.

Could you be the next exceptional person to join our team?

Cresset team